REPLY: Vutrisiran in ATTR-CM: Questions on Combination Therapy and Early Biomarker Kinetics

Fully automated analysis of cardiotoxicity surveillance echocardiograms: a direct test-retest precision comparison with experts.

European heart journal. Imaging methods and practice·2026

Sex Differences in a Contemporary, Real-World Cohort of Patients with Transthyretin Amyloid Cardiomyopathy Treated with Tafamidis.

Cardiology and therapy·2026

Effect of Vutrisiran According to Baseline Tafamidis Use in Transthyretin Amyloidosis With Cardiomyopathy: Insights From HELIOS-B.

Journal of the American College of Cardiology·2026

Influence of Disease-Modifying Therapy on the Efficacy of Vutrisiran in Transthyretin Cardiac Amyloidosis.

Journal of the American College of Cardiology·2026

Gene Silencer Therapy in Transthyretin Amyloid Cardiomyopathy: A Meta-Analysis of Outcomes Trials.

JAMA·2026

Electrocardiogram-Based Deep Learning to Prioritize Testing for Transthyretin Amyloid Cardiomyopathy.

JAMA·2026

Physiological Left Atrial Staging and the Risk of New-Onset Atrial Fibrillation in Hypertrophic Cardiomyopathy.

Journal of the American College of Cardiology·2026

Genetic Determinants of Early Heart Failure in Hypoplastic Left Heart Syndrome: A Prospective NC-DEFINE Study.

Journal of the American College of Cardiology·2026

Clinical Considerations for the Care of the Tactical Athlete With Cardiovascular Abnormalities: A Scientific Statement From the American College of Cardiology and the American Heart Association.

Journal of the American College of Cardiology·2026

Global, Regional, and National Burden of Myocarditis and Its Impairment, 1990-2023.

Journal of the American College of Cardiology·2026

Cold Spells, Heat Waves, and Nonoptimal Air Temperature and Risk of Heart Failure Hospitalization in Sweden.

Journal of the American College of Cardiology·2026

Protocol-Based Implementation of Early Intensive Lipid Management After Acute Coronary Syndrome: The BRIDGE Trial.

Journal of the American College of Cardiology·2026

Safety, feasibility, and exploratory biomarker findings of bone marrow-derived mesenchymal stromal cells in hospitalized severe COVID-19: a phase I/II randomized trial.

Journal of thoracic disease·2026

Efficacy and Safety of Intraventricular Thiotepa in Combination With Methotrexate for Leptomeningeal Metastasis From Breast Cancer (NJMU-BC04): A Single-Arm Phase II Study.

MedComm·2026

Development and external validation of a migraine analgesic usage (MAU) index for identifying high-severity migraine: A multi-center study.

Cephalalgia : an international journal of headache·2026

Cost-effectiveness of zanubrutinib versus ibrutinib as first-line treatment for patients with Waldenström macroglobulinemia in China.

Expert review of pharmacoeconomics & outcomes research·2026

Sigma-1 receptor involvement in the paradigm-dependent anti-amnesic effects of multimodal HBK-10 under NMDA receptor hypofunction, with accompanying hippocampal ERK1/2 and BDNF modulation.

Biochemical pharmacology·2026

Temporal trends in methamphetamine use among individuals receiving treatment for non-amphetamine substance use disorders (2015-2022): A repeat cross-sectional analysis.

Addictive behaviors·2026

Related Experiment Videos

REPLY: Vutrisiran in ATTR-CM: Questions on Combination Therapy and Early Biomarker Kinetics

Related Concept Videos

Fully automated analysis of cardiotoxicity surveillance echocardiograms: a direct test-retest precision comparison with experts.

Sex Differences in a Contemporary, Real-World Cohort of Patients with Transthyretin Amyloid Cardiomyopathy Treated with Tafamidis.

Effect of Vutrisiran According to Baseline Tafamidis Use in Transthyretin Amyloidosis With Cardiomyopathy: Insights From HELIOS-B.

Influence of Disease-Modifying Therapy on the Efficacy of Vutrisiran in Transthyretin Cardiac Amyloidosis.

Gene Silencer Therapy in Transthyretin Amyloid Cardiomyopathy: A Meta-Analysis of Outcomes Trials.

Electrocardiogram-Based Deep Learning to Prioritize Testing for Transthyretin Amyloid Cardiomyopathy.

Physiological Left Atrial Staging and the Risk of New-Onset Atrial Fibrillation in Hypertrophic Cardiomyopathy.

Genetic Determinants of Early Heart Failure in Hypoplastic Left Heart Syndrome: A Prospective NC-DEFINE Study.

Clinical Considerations for the Care of the Tactical Athlete With Cardiovascular Abnormalities: A Scientific Statement From the American College of Cardiology and the American Heart Association.

Global, Regional, and National Burden of Myocarditis and Its Impairment, 1990-2023.

Cold Spells, Heat Waves, and Nonoptimal Air Temperature and Risk of Heart Failure Hospitalization in Sweden.

Protocol-Based Implementation of Early Intensive Lipid Management After Acute Coronary Syndrome: The BRIDGE Trial.

Safety, feasibility, and exploratory biomarker findings of bone marrow-derived mesenchymal stromal cells in hospitalized severe COVID-19: a phase I/II randomized trial.

Efficacy and Safety of Intraventricular Thiotepa in Combination With Methotrexate for Leptomeningeal Metastasis From Breast Cancer (NJMU-BC04): A Single-Arm Phase II Study.

Development and external validation of a migraine analgesic usage (MAU) index for identifying high-severity migraine: A multi-center study.

Cost-effectiveness of zanubrutinib versus ibrutinib as first-line treatment for patients with Waldenström macroglobulinemia in China.

Sigma-1 receptor involvement in the paradigm-dependent anti-amnesic effects of multimodal HBK-10 under NMDA receptor hypofunction, with accompanying hippocampal ERK1/2 and BDNF modulation.

Temporal trends in methamphetamine use among individuals receiving treatment for non-amphetamine substance use disorders (2015-2022): A repeat cross-sectional analysis.

Related Experiment Videos

REPLY: Vutrisiran in ATTR-CM: Questions on Combination Therapy and Early Biomarker Kinetics

Related Concept Videos

Related Articles